These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 1697354)

  • 1. Kinins and converting enzyme inhibitors. A workshop. Königstein, Federal Republic of Germany. June 7-9, 1989. Proceedings.
    J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S1-109. PubMed ID: 1697354
    [No Abstract]   [Full Text] [Related]  

  • 2. Kinins and the vascular actions of converting enzyme inhibitors.
    Mombouli JV; Vanhoutte PM
    Curr Opin Nephrol Hypertens; 1994 Sep; 3(5):481-4. PubMed ID: 7804745
    [No Abstract]   [Full Text] [Related]  

  • 3. Kinin-related effects of angiotensin-converting enzyme inhibition.
    Bönner G
    Clin Physiol Biochem; 1990; 8 Suppl 1():6-15. PubMed ID: 2257722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.
    Linz W; Wiemer G; Gohlke P; Unger T; Schölkens BA
    Pharmacol Rev; 1995 Mar; 47(1):25-49. PubMed ID: 7784479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinins paracrine hormone.
    Carretero OA; Scicli AG
    Kidney Int Suppl; 1988 Oct; 26():S52-9. PubMed ID: 3059033
    [No Abstract]   [Full Text] [Related]  

  • 6. Kinins and cardioprotection.
    Wirth KJ; Linz W; Wiemer G; Schölkens BA
    Pharmacol Res; 1997 Jun; 35(6):527-30. PubMed ID: 9356203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of kinins and captopril in regulating arterial smooth muscle cell proliferation.
    Dixon BS; Dennis MJ
    Kidney Int Suppl; 1997 Oct; 61():S14-7. PubMed ID: 9328956
    [No Abstract]   [Full Text] [Related]  

  • 8. Kallikrein, kinins and blood pressure - effects of angiotensin-converting enzyme inhibition.
    Johnston CI; Clappison B; McGrath BP; Matthews PG; Millar JA; Anderson WP
    Prog Biochem Pharmacol; 1980; 17():123-33. PubMed ID: 6259649
    [No Abstract]   [Full Text] [Related]  

  • 9. Kinins and endothelium-dependent relaxations to converting enzyme inhibitors in perfused canine arteries.
    Mombouli JV; Vanhoutte PM
    J Cardiovasc Pharmacol; 1991 Dec; 18(6):926-7. PubMed ID: 1725908
    [No Abstract]   [Full Text] [Related]  

  • 10. Kinins, receptors, kininases and inhibitors--where did they lead us?
    Erdös EG; Marcic BM
    Biol Chem; 2001 Jan; 382(1):43-7. PubMed ID: 11258670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Converting enzyme inhibitors and the interaction between kinins and eicosanoids.
    Schrör K
    J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S60-8. PubMed ID: 1697363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinin-mediated coronary nitric oxide production contributes to the therapeutic action of angiotensin-converting enzyme and neutral endopeptidase inhibitors and amlodipine in the treatment in heart failure.
    Zhang X; Recchia FA; Bernstein R; Xu X; Nasjletti A; Hintze TH
    J Pharmacol Exp Ther; 1999 Feb; 288(2):742-51. PubMed ID: 9918584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of kinin system to the antihypertensive action of angiotensin converting enzyme inhibitors.
    Sharma JN
    Adv Exp Med Biol; 1989; 247A():197-205. PubMed ID: 2690588
    [No Abstract]   [Full Text] [Related]  

  • 14. Angiotensin-converting enzyme inhibitors and the kallikrein-kinin system.
    Shimamoto K; Matsuki T; Iimura O
    J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S83-90. PubMed ID: 1697368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Do kinins have significance for the antihypertensive effect of angiotensin-converting enzyme inhibitors?].
    Bönner G
    Z Kardiol; 1988; 77 Suppl 3():23-7. PubMed ID: 3062958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy.
    Tschöpe C; Seidl U; Reinecke A; Riester U; Graf K; Schultheiss HP; Hilgenfeldt U; Unger T
    Int Immunopharmacol; 2003 Mar; 3(3):335-44. PubMed ID: 12639811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinin- and non-kinin-mediated interactions of converting enzyme inhibitors with vasoactive hormones.
    Kramer HJ; Glänzer K; Meyer-Lehnert H; Mohaupt M; Predel HG
    J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S91-8. PubMed ID: 1697369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinins and the laxative effect of phenolphthalein.
    Autore G; Mascolo N; Capasso F
    Pharmacol Res; 1990; 22 Suppl 1():105-6. PubMed ID: 2178254
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibitor analysis of angiotensin I-converting and kinin-degrading activities of bovine lung and testicular angiotensin-converting enzyme.
    Grinshtein SV; Binevski PV; Gomazkov OA; Pozdnev VF; Nikolskaya II; Kost OA
    Biochemistry (Mosc); 1999 Aug; 64(8):938-44. PubMed ID: 10498812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current and future trends in hypertension. Proceedings of a meeting. Heidelberg, Federal Republic of Germany, September 7, 1986.
    J Cardiovasc Pharmacol; 1987; 9 Suppl 3():S1-110. PubMed ID: 2442544
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.